Choong-wae seeks 1 trillion won sales with new cancer treatment

Published: 2010-03-19 06:56:00
Updated: 2010-03-19 06:56:00
Choong-wae Pharm announces that it will embark on phase I study of “CWP-231A”, a first-in-class candidate anticancer medicine targeting Wnt proteins.

The company said it will seek the approval of clinical studies by the U.S. Food and Drug Administration at the end of this month to develop the ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.